UK medicines regulator will consider new data on COVID-19 antiviral ‘rebound’ with Paxlovid

Exclusive: The Medicines and Healthcare products Regulatory Agency will look at new trial data requested by the US Food and Drug Administration, owing to reports of people testing positive for COVID-19 after treatment with Paxlovid.…
Published: 26 August 2022